Page last updated: 2024-08-26

arsenic and selegiline

arsenic has been researched along with selegiline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, SG; Lee, CH; Park, JW	1

Other Studies

1 other study(ies) available for arsenic and selegiline

Article	Year
Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation. Journal of toxicology and environmental health. Part A, 2004, Volume: 67, Issue:23-24 Topics: Animals; Antiparkinson Agents; Arsenic; Carcinoma, Hepatocellular; Cell Culture Techniques; Drug Interactions; Glutathione; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 4; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Rats; Selegiline; Tumor Cells, Cultured	2004

Article

Year

Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation.

Journal of toxicology and environmental health. Part A, 2004, Volume: 67, Issue:23-24

Topics: Animals; Antiparkinson Agents; Arsenic; Carcinoma, Hepatocellular; Cell Culture Techniques; Drug Interactions; Glutathione; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 4; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Rats; Selegiline; Tumor Cells, Cultured

2004